Evidence map›Paper›PMID 42156404›Full record

ArticleNature communications2026

A Stratification Method for Identifying Subgroups at High-Risk for Type 2 Diabetes in sub-Saharan Africa.

Kayode E Adetunji, Theophilous Mathema, Isaac Kisiangani, Okechinyere Achilonu, Daniel Nderitu Maina, Samuel Iddi, Nigel John Crowther, Alisha N Wade, Gershim Asiki, Palwendé Romuald Boua and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kayode E AdetunjiSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. kayode.adetunji1@wits.ac.za.ORCID http://orcid.org/0000-0003-0504-382X
Theophilous MathemaSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Isaac KisianganiAfrican Population and Health Research Center, Nairobi, Kenya.ORCID http://orcid.org/0000-0002-1107-4334
Okechinyere AchilonuSchool of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Daniel Nderitu MainaAfrican Population and Health Research Center, Nairobi, Kenya.ORCID http://orcid.org/0000-0001-9800-2431
Samuel IddiAfrican Population and Health Research Center, Nairobi, Kenya.
Nigel John CrowtherDepartment of Chemical Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Alisha N WadeResearch in Metabolism and Endocrinology, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID http://orcid.org/0000-0002-1158-2523
Gershim AsikiAfrican Population and Health Research Center, Nairobi, Kenya.ORCID http://orcid.org/0000-0002-9966-1153
Palwendé Romuald BouaSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Michelle KampSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID http://orcid.org/0000-0002-4334-6883
Given MashabaDIMAMO Population Health Research Center, University of Limpopo, Polokwane, South Africa.
Stephen TollmanSchool of Public Health, University of the Witwatersrand, Johannesburg, South Africa.ORCID http://orcid.org/0000-0003-0744-7588
Michèle RamsaySydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. michele.ramsay@wits.ac.za.ORCID http://orcid.org/0000-0002-4156-4801
Skyler SpeakmanIBM Research, Nairobi, Kenya.
Scott HazelhurstSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. scott.hazelhurst@wits.ac.za.ORCID http://orcid.org/0000-0002-0581-149X

Funding

MADIVA (Multimorbidity in Africa: Digital innovation, visualisation and application)U54TW012077 · FIC · WITS HEALTH CONSORTIUM (PTY), LTD · PI Scott Hazelhurst, Stephen Tollman · 2021 to 2026
$6.9M
FIC NIH HHS U54 TW012077U.S. Department of Health & Human Services | NIH | Fogarty International Center (FIC) U54 TW 012077
6 · The paper itself

Abstract

Type 2 diabetes is rising globally, with sub-Saharan Africa facing the steepest projected increase. In low-resource settings, limited screening contributes to high rates of undiagnosed disease, delaying intervention. Traditional risk models often rely on single-factor thresholds or population averages, which can miss combinations of demographic, anthropometric, and lifestyle factors relevant in African contexts. However, emerging evidence suggests that interactions between multiple risk factors provide more accurate, region-specific characterizations of risk. We applied a multidimensional subgroup discovery algorithm to cross-sectional data from three African populations and identified combinations of risk factor cutoffs that define high-risk subgroups. The most consistent profile, such as waist-to-hip ratio greater than 0.9, physical activity less than or equal to 2448 metabolic equivalent-minutes per week, and family history, shows elevated risk across regions and outperforms guideline-based definitions. Here we show that core anthropometric and familial factors are stable across populations, while others are region-specific, improving predictive performance for screening.

Indexed as

Diabetes Mellitus, Type 2AdultAfrica South of the SaharaAlgorithmsCross-Sectional StudiesExerciseFemaleHumansMaleMiddle AgedRisk FactorsSub-Saharan African PeopleWaist-Hip Ratio

Identifiers

PMID42156404
PMCPMC13462992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.